Affecting the effectors: JAK inhibitors modulation of immune cell numbers and functions in patients with rheumatoid arthritis-Reference-Cited by-同舟云学术

Affecting the effectors: JAK inhibitors modulation of immune cell numbers and functions in patients with rheumatoid arthritis

Published:2022-02-25 Issue:3 Volume:18 Page:309-319
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Garufi Cristina¹,Maclean Mary²,Gadina Massimo²,Spinelli Francesca Romana¹

Affiliation:

1. Sapienza Università di Roma, Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari—Reumatologia, Roma, Italia

2. Translational Immunology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA

Funder

funding

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2022.2042254

Reference93 articles.

1. The Pathogenesis of Rheumatoid Arthritis

2. O’Shea JJ, Gadina M, and Siegel R, et al. 2018. Rheumatology: cytokine. 7th ed. Philadelphia, PA: Elsevier; 86–100.

3. JAKs and STATs in Immunity, Immunodeficiency, and Cancer

4. Historical review: Cytokines as therapeutics and targets of therapeutics

5. Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin-15 is a hair follicle immune privilege guardian;Journal of Autoimmunity;2024-05

2. Revealing the changes in signaling pathways caused by tofacitinib in patients with rheumatoid arthritis through RNA sequencing and the correlation with clinical parameters;Clinical Rheumatology;2024-03-16

3. Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes;New England Journal of Medicine;2023-12-07

4. Infectious adverse events in patients with atopic dermatitis treated with baricitinib;Immunotherapy;2023-12

5. JAK inhibitors: Is specificity at all relevant?;Seminars in Arthritis and Rheumatism;2023-11